• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The effects of desmopressin on hemostatic parameters in the normal dog.去氨加压素对正常犬止血参数的影响。
Can J Vet Res. 1986 Apr;50(2):265-71.
2
Oncotic, hemodilutional, and hemostatic effects of isotonic saline and hydroxyethyl starch solutions in clinically normal ponies.等渗盐水和羟乙基淀粉溶液对临床正常小马的胶体渗透压、血液稀释及止血作用
Am J Vet Res. 1997 May;58(5):541-8.
3
Local and systemic effects of intra-arterial desmopressin in healthy volunteers and patients with type 3 von Willebrand disease. Role of interleukin-6.动脉内注射去氨加压素对健康志愿者和3型血管性血友病患者的局部和全身影响。白细胞介素-6的作用。
Thromb Haemost. 2000 Aug;84(2):195-203.
4
Desmopressin (DDAVP) for treatment of disorders of hemostasis.去氨加压素(DDAVP)用于治疗止血障碍。
Prog Hemost Thromb. 1986;8:19-45.
5
Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia.去氨基-8-D-精氨酸加压素可缩短尿毒症患者的出血时间。
N Engl J Med. 1983 Jan 6;308(1):8-12. doi: 10.1056/NEJM198301063080102.
6
Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.获得性血管性血友病综合征:临床特征、病因、病理生理学、分类及管理
Best Pract Res Clin Haematol. 2001 Jun;14(2):401-36. doi: 10.1053/beha.2001.0141.
7
Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.1型和2型先天性血管性血友病患者血管性血友病因子参数对去氨加压素的反应:诊断和治疗意义
Semin Thromb Hemost. 2002 Apr;28(2):111-32. doi: 10.1055/s-2002-27814.
8
Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.抗血友病因子浓缩物中蛋白酶的特性:通过高压凝胶渗透色谱法评估对凝血因子VIII:血管性血友病因子的影响。
J Lab Clin Med. 1984 Nov;104(5):816-28.
9
Failure of sodium pentobarbital anesthesia to alter 1-desamino-8-D-arginine vasopressin-induced elevations of plasma factor VIII/ von Willebrand factor in normal dogs.戊巴比妥钠麻醉未能改变1-去氨基-8-D-精氨酸血管加压素诱导的正常犬血浆因子VIII/血管性血友病因子升高。
Can J Vet Res. 1988 Oct;52(4):416-8.
10
The effect of desamino-D-arginine vasopressin (DDAVP) and naloxone infusions on factor VIII and possible endothelial cell (EC) related activities.去氨基-D-精氨酸血管加压素(DDAVP)和纳洛酮输注对凝血因子VIII及可能的内皮细胞相关活性的影响。
Br J Haematol. 1984 Aug;57(4):651-62.

引用本文的文献

1
Hemostatic studies in a newfoundland dog with idiopathic epistaxis.一只患有特发性鼻出血的纽芬兰犬的止血研究。
Can Vet J. 1988 Jan;29(1):62-4.
2
Canine Von Willebrand's Disease: A Common Inherited Bleeding Disorder in Doberman Pinscher Dogs.犬血管性血友病:杜宾犬常见的遗传性出血性疾病。
Can Vet J. 1986 Sep;27(9):315-8.
3
Desmopressin enhances the binding of plasma von Willebrand factor to collagen in plasmas from normal dogs and dogs with type I von Willebrand's disease.去氨加压素可增强正常犬和I型血管性血友病犬血浆中血管性血友病因子与胶原蛋白的结合。
Can Vet J. 1999 Sep;40(9):645-8.
4
Failure of sodium pentobarbital anesthesia to alter 1-desamino-8-D-arginine vasopressin-induced elevations of plasma factor VIII/ von Willebrand factor in normal dogs.戊巴比妥钠麻醉未能改变1-去氨基-8-D-精氨酸血管加压素诱导的正常犬血浆因子VIII/血管性血友病因子升高。
Can J Vet Res. 1988 Oct;52(4):416-8.
5
The effects of desmopressin on plasma factor VIII/von Willebrand factor activity in dogs with von Willebrand's disease.去氨加压素对患有血管性血友病的犬血浆凝血因子VIII/血管性血友病因子活性的影响。
Can J Vet Res. 1987 Apr;51(2):189-93.

本文引用的文献

1
Evidence for endogenous opioid control of vasopressin release in man.人体内阿片肽对血管加压素释放的内源性控制的证据。
J Clin Endocrinol Metab. 1980 Mar;50(3):569-71. doi: 10.1210/jcem-50-3-569.
2
Von Willebrand's disease in two families of Doberman Pinschers.杜宾犬两个家族中的血管性血友病。
Can Vet J. 1981 Aug;22(8):239-43.
3
Clinical experience with arginine vasopressin (DDAVP) in von Willebrand's disease and mild haemophilia.精氨酸加压素(DDAVP)用于血管性血友病和轻度血友病的临床经验。
N Z Med J. 1980 Nov 26;92(672):375-8.
4
The role of the spleen in regulating the plasma levels of factor VIII--von Willebrand's factor after DDAVP.去氨加压素后脾脏在调节血浆VIII因子-血管性血友病因子水平中的作用
Blood. 1982 Dec;60(6):1402-6.
5
A canine model of hemophilic (factor VIII:C deficiency) bleeding.血友病(因子VIII:C缺乏)出血的犬类模型。
Blood. 1982 Sep;60(3):727-30.
6
Synthesis and release of factor VIII by cultured human endothelial cells.培养的人内皮细胞中凝血因子VIII的合成与释放
Br J Haematol. 1981 Apr;47(4):617-26. doi: 10.1111/j.1365-2141.1981.tb02691.x.
7
Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease.健康受试者、甲型血友病患者及血管性血友病患者中因子VIII/血管性血友病因子对去氨加压素的反应。
Br J Haematol. 1981 Feb;47(2):283-93. doi: 10.1111/j.1365-2141.1981.tb02789.x.
8
Factor VII and fibrinolytic response to deamino-8-D-argenine vasopressin in normal subjects and dissociate response in some patients with haemophilia and von Willebrand's disease.正常受试者中因子 VII 及对去氨基-8-D-精氨酸加压素的纤溶反应,以及血友病和血管性血友病患者中的分离反应。
Br J Haematol. 1980 Jul;45(3):499-511. doi: 10.1111/j.1365-2141.1980.tb07169.x.
9
Effects of DDAVP and venous occlusion on the release of tissue-type plasminogen activator and von Willebrand factor in patients with panhypopituitarism.去氨加压素和静脉阻塞对全垂体功能减退症患者组织型纤溶酶原激活物和血管性血友病因子释放的影响。
Thromb Res. 1984 Mar 15;33(6):653-9. doi: 10.1016/0049-3848(84)90120-8.
10
The effect of DDAVP on plasma levels of von Willebrand antigen II in normal individuals and patients with von Willebrand's disease.去氨加压素对正常个体及血管性血友病患者血管性血友病因子抗原II血浆水平的影响。
Blood. 1984 Mar;63(3):532-5.

去氨加压素对正常犬止血参数的影响。

The effects of desmopressin on hemostatic parameters in the normal dog.

作者信息

Johnstone I B, Crane S

出版信息

Can J Vet Res. 1986 Apr;50(2):265-71.

PMID:3093039
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1255201/
Abstract

Seven normal unanesthetized dogs were infused with desmopressin in saline (doses 0.2, 0.4 and 0.6 micrograms/kg i.v.) or saline alone, on separate occasions in order to determine the effects of desmopressin on circulating factor VIII coagulant and factor VIII-related antigen activities, on partial thromboplastin times and prothrombin times, on blood platelet count and packed cell volume, and on serum osmolarity. Desmopressin caused a rapid dose-dependent elevation in both factor VIII activities peaking at 30-60 minutes postinfusion. At a dosage of 0.6 microgram/kg desmopressin induced rises in factor VIII coagulant activity and factor VIII-related antigen of 150% and 198% of the preinfusion levels respectively, while the half disappearance times were approximately five and six hours respectively. The other parameters were not significantly affected by even the highest dose of desmopressin used. These results indicate that normal dogs respond to desmopressin in a manner similar to man. The major differences are in the dosage required to produce comparable effects (higher in dogs), and in the fact that the factor VIII-related antigen activity consistently responds to a greater degree than the coagulant activity. It is concluded that desmopressin may have particular value in stimulating elevations in plasma factor VIII-related antigen in dogs deficient in this plasma protein. Six dogs were pretreated with the endorphin inhibitor, naloxone, (0.04 mg/kg I.V.) or sterile saline, three minutes prior to infusion with desmopressin at a dose of 0.6 microgram/kg i.v.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

七只未麻醉的正常犬,分别在不同时间静脉注射去氨加压素生理盐水溶液(剂量为0.2、0.4和0.6微克/千克)或仅注射生理盐水,以确定去氨加压素对循环中凝血因子VIII活性和因子VIII相关抗原活性、部分凝血活酶时间和凝血酶原时间、血小板计数和红细胞压积以及血清渗透压的影响。去氨加压素导致两种因子VIII活性迅速出现剂量依赖性升高,在输注后30 - 60分钟达到峰值。在剂量为0.6微克/千克时,去氨加压素使因子VIII凝血活性和因子VIII相关抗原分别升高至输注前水平的150%和198%,而半衰期分别约为5小时和6小时。即使使用最高剂量的去氨加压素,其他参数也未受到显著影响。这些结果表明,正常犬对去氨加压素的反应与人相似。主要差异在于产生可比效应所需的剂量(犬更高),以及因子VIII相关抗原活性始终比凝血活性反应程度更大这一事实。结论是,去氨加压素在刺激缺乏这种血浆蛋白的犬血浆中因子VIII相关抗原升高方面可能具有特殊价值。六只犬在静脉注射0.6微克/千克去氨加压素前3分钟,预先静脉注射内啡肽抑制剂纳洛酮(0.04毫克/千克)或无菌生理盐水。(摘要截短至250字)